Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eledon Pharmaceuticals (ELDN) Other Non Operating Income (2016 - 2026)

Eledon Pharmaceuticals filings provide 4 years of Other Non Operating Income readings, the most recent being -$5000.0 for Q4 2017.

  • On a quarterly basis, Other Non Operating Income rose 89.58% to -$5000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $5000.0, a 101.04% increase, with the full-year FY2024 number at $3.9 million, up 46.75% from a year prior.
  • Other Non Operating Income hit -$5000.0 in Q4 2017 for Eledon Pharmaceuticals, roughly flat from -$5000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $54000.0 in Q1 2016 to a low of -$418000.0 in Q3 2016.
  • Median Other Non Operating Income over the past 4 years was $4000.0 (2017), compared with a mean of -$32545.5.
  • The widest YoY moves for Other Non Operating Income: up 105.71% in 2017, down 79.63% in 2017.
  • Eledon Pharmaceuticals' Other Non Operating Income stood at $45000.0 in 2014, then fell by 11.11% to $40000.0 in 2015, then crashed by 220.0% to -$48000.0 in 2016, then soared by 89.58% to -$5000.0 in 2017.
  • The last three reported values for Other Non Operating Income were -$5000.0 (Q4 2017), -$5000.0 (Q3 2017), and $4000.0 (Q2 2017) per Business Quant data.